These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 48183

  • 21. [Clinical study of a new anti-arrhythmic drug: propafenon. Short and long-term results].
    Ruipércz Abizanda JA, Campos Peris JV, García García J, Jaen Armand E, Ruiz Ros JA, Salas Nieto J, Rodríguez Ruiz P, Marco Quiles J, Martínez Jérez M, Pico Aracil F.
    Arch Inst Cardiol Mex; 1981; 51(4):371-6. PubMed ID: 7337481
    [Abstract] [Full Text] [Related]

  • 22. [Cordaron in the treatment of patients with paroxysmal rhythm disorders].
    Kiseleva LN, Nekrasova LF.
    Vrach Delo; 1986 Mar; (3):28-31. PubMed ID: 2424177
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent.
    Klein G, Wirtzfeld A, Alt E, Steck J, Saunders R, Hulse J, Kartzinel R, Lee R, Laddu AR.
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):112-7. PubMed ID: 6142005
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Combined use of propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)].
    Beck OA, Hochrein H.
    Dtsch Med Wochenschr; 1980 Sep 05; 105(36):1243-6. PubMed ID: 6159147
    [Abstract] [Full Text] [Related]

  • 31. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF, Georgiopoulos G, Halkidis H, Attuel P, Maisonblanche P, Coumel P.
    Arch Mal Coeur Vaiss; 1981 Dec 05; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract] [Full Text] [Related]

  • 32. [Hemodynamic effects of propafenone in acute myocardial infarct].
    Finzi A, Ambrosini F, Pagnoni F, Massari FM, Valentini R, Lotto A.
    G Ital Cardiol; 1984 May 05; 14(5):367-72. PubMed ID: 6468818
    [Abstract] [Full Text] [Related]

  • 33. Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
    Gettes LS.
    Cardiovasc Clin; 1970 May 05; 2(2):211-37. PubMed ID: 4149974
    [No Abstract] [Full Text] [Related]

  • 34. [Disamide--an antiarrhythmic agent in cardiovascular diseases].
    Kalmykova VI, Barkhatova VM.
    Ter Arkh; 1968 Jan 05; 40(1):108-10. PubMed ID: 4194896
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
    Palmieri M, Capucci A, Lombardi G, Naccarella F, Bomba E, Bracchetti D.
    G Ital Cardiol; 1984 May 05; 14(5):357-9. PubMed ID: 6468817
    [Abstract] [Full Text] [Related]

  • 38. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L, Breithardt G, Both A.
    Z Kardiol; 1975 Aug 05; 64(8):731-40. PubMed ID: 1163095
    [Abstract] [Full Text] [Related]

  • 39. [Electrophysiologic effects of intravenous carocainide].
    Zannad F, Aliot E, Baille N, Gilgenkrantz JM.
    Arch Mal Coeur Vaiss; 1986 Feb 05; 79(2):236-41. PubMed ID: 3085623
    [Abstract] [Full Text] [Related]

  • 40. [Observations on the effect of Inderal on hemodynamics and arrhythmias in man].
    Lujf A, Moser K.
    Wien Klin Wochenschr; 1967 May 05; 79(18):343-9. PubMed ID: 4171906
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.